Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Neoplasms 8 cyclopia sequence 7 Prostatic Neoplasms 7 Polycystic Ovary Syndrome 5 Fatigue 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Obesity 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Leiomyoma 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Insulin Resistance 2 Infertility 2 Hyperandrogenism 2 Hematologic Diseases 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1

Interventions

Surveys and Questionnaires 5 Oxygen 2 Dexamethasone 2 Calcium Dobesilate 2 Acupuncture Therapy 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Standard of Care 1 Respiratory Therapy 1 Rehabilitation 1 Psychiatric Rehabilitation 1 Midazolam 1 Losartan 1 Lisinopril 1 Hypnosis 1 Hematologic Tests 1 Furosemide 1 Fentanyl 1 Exercise 1 Educational Status 1 Echocardiography 1 Early Intervention, Educational 1 Dexmedetomidine 1 Caregivers 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Dyspnea × Sugars × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡